1. A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma. (May 2023) Authors: Liang, Qian; Gong, Miaomiao; Zou, Jing-Hua; Luo, Ming-yu; Jiang, Lu-lu; Wang, Cheng; Shen, Ning-xiang; Zhang, Mo-cong; Xu, Lu; Lei, Hui-min; Zhang, Ke-Ren; Zhang, Rui; Zhuang, Guanglei; Zhu, Liang; Chen, Hong-zhuan; Zhou, Lu; Shen, Ying Journal: Drug resistance updates Issue: Volume 68(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗